---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-26-000011"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:39:18.283865+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Intensity Therapeutics updates investor slide with preliminary FY2025 financial highlights

## Summary
- Slide dated March 4, 2026, presents unaudited financial highlights through December 31, 2025.
- Figures are preliminary and subject to completion of financial closing procedures; may differ materially from final results.
- Slide is available on the Investor Relations section of the company's website.
- No specific revenue, earnings, or balance sheet numbers are disclosed in the 8-K or its exhibit.

## SEC filing metadata
- accession: 0001567264-26-000011
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000011/0001567264-26-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000011/intensity-20260305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-26-000011
- JSON: https://secwatch.observer/filing/0001567264-26-000011.json
- Plain text: https://secwatch.observer/filing/0001567264-26-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.